Key researchers in Haematopoietic Stem Cell Transplant (HSCT)

Dr Jennifer Massey (St Vincent’s Hospital, Sydney) and Dr Zoe Dyer (Auckland Hospital), alongside Brett Drummond (MStranslate) discuss:

  • HSCT and how it works
  • Our current understanding of this treatment
  • Those most likely to achieve successful outcomes, risks and worldwide options.
Watch the Video

Video Summary

  • Length – 35 minutes
  • Treatment Objectives (NEDA): The concept of “No Evidence of Disease Activity” (NEDA), which includes the absence of relapses, new MRI lesions, and disability progression.
  • Eligibility & Timing: Discussion on the “sweet spot” for treatment.
  • Safety & Risk Profile: A breakdown of the chemotherapy process and side effects.
  • The EBV Connection: An overview of the link between the Epstein-Barr Virus and MS, and the theory that HSCT might work by “resetting” the immune system’s dysfunctional response to the virus.
  • Regional Availability: Practical information on accessing the treatment in New Zealand.
  • Rehabilitation: The necessity of neurological physiotherapy post-transplant.
  • Overseas Clinics: A cautious discussion regarding private clinics in Mexico and Russia, emphasizing the importance of local medical consultation before traveling for treatment.

Explore our Support Services

Support Services
Translate »